Frontier Medicines Announces Oral Presentation on Dual-Acting Inhibitors of the Active and Inactive Forms of KRAS G12C at the American Association for Cancer Research (AACR) Annual Meeting
09 mars 2022 08h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer
08 mars 2022 08h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board
08 févr. 2022 08h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie
10 janv. 2022 07h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 janv. 2022 08h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference
09 déc. 2021 08h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer
17 nov. 2021 08h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at Two Upcoming Investor Conferences in November
10 nov. 2021 16h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at the Cantor Global Healthcare Conference
23 sept. 2021 08h00 HE
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline
19 juil. 2021 08h00 HE
|
Frontier Medicines
—Funding to Enhance Research and Development of Pipeline, Including Lead Program Targeting Activated KRASG12C— —Proceeds to Further Accelerate the Development of Foundational Technologies in...